Cantitate/Preț
Produs

The Medical Management of Prostate Cancer: ESO Monographs

Editat de Louis Denis
en Limba Engleză Paperback – 12 feb 2012
Starting in 1986, the European School of Oncology has expanded its activities in postgraduate teaching, which consisted mainly of traditional disease-orientated courses, by promoting new educational initiatives. One of these is the cloister seminars, short meetings intended for highly qualified oncologists and dealing with specific, controversial aspects of clinical practice and research. Another is the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on developments and treatment in specific fields of oncology. This series of ESO Monographs was designed with the specific purpose of disseminating the results of the most interesting of the seminars and study groups, and providing concise and updated reviews of the subjects discussed. It wa& decided to keep the layout very simple in order to keep costs to a minimum and make the monographs available in the shortest possible time, thus overcoming a common problem in medical literature: that of the material being outdated even before publication.
Citește tot Restrânge

Din seria ESO Monographs

Preț: 67464 lei

Preț vechi: 71015 lei
-5% Nou

Puncte Express: 1012

Preț estimativ în valută:
12912 13709$ 10696£

Carte tipărită la comandă

Livrare economică 25 decembrie 24 - 08 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642732409
ISBN-10: 3642732402
Pagini: 116
Ilustrații: IX, 98 p.
Dimensiuni: 210 x 280 x 6 mm
Greutate: 0.28 kg
Ediția:Softcover reprint of the original 1st ed. 1988
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria ESO Monographs

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Aspects of Epidemiology, Pathogenesis and Natural History of Prostatic Cancer.- Oncogenes, Tumour Markers and Monoclonal Antibodies.- The Endocrinological Basis for Hormonal Therapy.- Estrogens and Estramustine Phosphate.- Antiandrogens.- Luteinizing Hormone Releasing Hormone Agonists.- Chemical Adrenal Blockade Treatment.- Total Androgen Blockade.- Second-Line Endocrine Treatment.- Chemotherapy.- The Clinical and Financial Implications of Immediate or Deferred Treatment in Patients with Advanced Prostatic Cancer.- Treatment Recommendations for Daily Practice.